OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and the Value of Traditional Chinese Medicine Treatment
Wentao Jia, Shufang Liang, Binbin Cheng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
Wentao Jia, Shufang Liang, Binbin Cheng, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 26
Showing 1-25 of 26 citing articles:
Cancer-Associated Fibroblasts in Hepatocellular Carcinoma and Cholangiocarcinoma
Ying Fan, Mandy Sze Man Chan, Terence K. Lee
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 4, pp. 985-999
Open Access | Times Cited: 49
Ying Fan, Mandy Sze Man Chan, Terence K. Lee
Cellular and Molecular Gastroenterology and Hepatology (2023) Vol. 15, Iss. 4, pp. 985-999
Open Access | Times Cited: 49
Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
Shiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 40
Shiming Tan, Yiqing Yang, Wenjuan Yang, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 40
Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma
Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3441-3441
Open Access | Times Cited: 23
Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3441-3441
Open Access | Times Cited: 23
Bioactive sphingolipids as emerging targets for signal transduction in cancer development
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189176-189176
Closed Access | Times Cited: 7
Wentao Jia, Jiaying Yuan, Jinbo Zhang, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189176-189176
Closed Access | Times Cited: 7
Metabolic reprogramming in hepatocellular carcinoma: mechanisms of immune evasion and therapeutic implications
Bo Gao, Yan Lu, Xingyue Lai, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Bo Gao, Yan Lu, Xingyue Lai, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Heterogeneity and interplay: the multifaceted role of cancer-associated fibroblasts in the tumor and therapeutic strategies
Qiaoqiao Liu, Fei Yao, Liangliang Wu, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2395-2417
Closed Access | Times Cited: 2
Qiaoqiao Liu, Fei Yao, Liangliang Wu, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2395-2417
Closed Access | Times Cited: 2
Identification of MTCH1 as a novel prognostic indicator and therapeutic target in hepatocellular carcinoma
Liangpeng Xie, Yufeng Shu, Mingzhu Ye, et al.
Pathology - Research and Practice (2024) Vol. 259, pp. 155358-155358
Open Access | Times Cited: 2
Liangpeng Xie, Yufeng Shu, Mingzhu Ye, et al.
Pathology - Research and Practice (2024) Vol. 259, pp. 155358-155358
Open Access | Times Cited: 2
Targeting cancer-associated fibroblasts/tumor cells cross-talk inhibits intrahepatic cholangiocarcinoma progression via cell-cycle arrest
Serena Mancarella, Isabella Gigante, Elena Antinoro Pizzuto, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Serena Mancarella, Isabella Gigante, Elena Antinoro Pizzuto, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Reveal the mechanisms of prescriptions for liver cancer' treatment based on two illustrious senior TCM physicians.
Bochuan Wang, Yong Zhang, Qiuyun Zhang, et al.
PubMed (2023) Vol. 43, Iss. 1, pp. 188-197
Closed Access | Times Cited: 4
Bochuan Wang, Yong Zhang, Qiuyun Zhang, et al.
PubMed (2023) Vol. 43, Iss. 1, pp. 188-197
Closed Access | Times Cited: 4
Regulation of Fuzheng Huayu capsule on inhibiting the fibrosis-associated hepatocellular carcinogenesis
Wenqi Zhang, Jiaxin Sun, Shuting Lan, et al.
Journal of Asian Natural Products Research (2024) Vol. 26, Iss. 10, pp. 1219-1238
Closed Access | Times Cited: 1
Wenqi Zhang, Jiaxin Sun, Shuting Lan, et al.
Journal of Asian Natural Products Research (2024) Vol. 26, Iss. 10, pp. 1219-1238
Closed Access | Times Cited: 1
Targeting glutamine metabolism crosstalk with tumor immune response
Chenshuang Dong, Yan Zhao, Yecheng Han, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189257-189257
Closed Access | Times Cited: 1
Chenshuang Dong, Yan Zhao, Yecheng Han, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024), pp. 189257-189257
Closed Access | Times Cited: 1
Investigating the Role of Dahuang in Hepatoma Treatment Using Network Pharmacology, Molecular Docking, and Survival Analysis
Bin Yu, Maoru Wang, Hui Xu, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 6
Bin Yu, Maoru Wang, Hui Xu, et al.
BioMed Research International (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 6
Arisaema heterophyllum Blume Monomer Stigmasterol Targets PPARγ and Inhibits the Viability and Tumorigenicity of Lung Adenocarcinoma Cells NCI-H1975
Na Song, Jing Wang, Zonglang Lai, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 6
Na Song, Jing Wang, Zonglang Lai, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 6
Overcoming the therapeutic resistance of hepatomas by targeting the tumor microenvironment
Jiaxin Zhang, Huiqiong Han, Lei Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Jiaxin Zhang, Huiqiong Han, Lei Wang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
Systematic analysis of the role and significance of target genes of active ingredients of traditional Chinese medicine injections in the progression and immune microenvironment of hepatocellular carcinoma
Chao Wang, Lili Yang, Shaoheng Xu, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 3
Chao Wang, Lili Yang, Shaoheng Xu, et al.
Frontiers in Pharmacology (2023) Vol. 13
Open Access | Times Cited: 3
Network Pharmacology Combined with Experimental Validation Reveals the Anti-tumor Effect of Duchesnea indica against Hepatocellular Carcinoma
Xing Liu, Kesheng Wang, Luling Wang, et al.
Journal of Cancer (2023) Vol. 14, Iss. 4, pp. 505-518
Open Access | Times Cited: 3
Xing Liu, Kesheng Wang, Luling Wang, et al.
Journal of Cancer (2023) Vol. 14, Iss. 4, pp. 505-518
Open Access | Times Cited: 3
The role of dysregulated mRNA translation machinery in cancer pathogenesis and therapeutic value of ribosome-inactivating proteins
Wentao Jia, Jiaying Yuan, Shu Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189018-189018
Open Access | Times Cited: 3
Wentao Jia, Jiaying Yuan, Shu Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189018-189018
Open Access | Times Cited: 3
RAB42 is a Potential Biomarker that Correlates With Immune Infiltration in Hepatocellular Carcinoma
Hao Peng, Xuanlong Du, Yewei Zhang
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 4
Hao Peng, Xuanlong Du, Yewei Zhang
Frontiers in Molecular Biosciences (2022) Vol. 9
Open Access | Times Cited: 4
RAB6B is a potential prognostic marker and correlated with the remolding of tumor immune microenvironment in hepatocellular carcinoma
Hao Peng, Erwei Zhu, Ji‐Tao Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Hao Peng, Erwei Zhu, Ji‐Tao Wang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 3
Huaier granule improves liver inflammation and fibrosis and prevents recurrence in hepatitis B virus related hepatocellular carcinoma
Qionglan Wu, Jinhua Zeng, Jianxing Zeng, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 569-578
Open Access
Qionglan Wu, Jinhua Zeng, Jianxing Zeng, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 569-578
Open Access
[Hepatocellular Carcinoma-Derived Exosomes: Key Players in Intercellular Communication Within the Tumor Microenvironment].
Feng Tang, Xinrui Yang, Qiwei Wang, et al.
PubMed (2024) Vol. 55, Iss. 1, pp. 6-12
Closed Access
Feng Tang, Xinrui Yang, Qiwei Wang, et al.
PubMed (2024) Vol. 55, Iss. 1, pp. 6-12
Closed Access
Investigating the Potential Mechanism of Huazhi Rougan Granules Against Alcoholic Liver Disease by Network Pharmacology and Experiment
Yingying Tan, Yingying Liu, Yiyan Zhai, et al.
World Journal of Traditional Chinese Medicine (2024) Vol. 10, Iss. 2, pp. 191-203
Open Access
Yingying Tan, Yingying Liu, Yiyan Zhai, et al.
World Journal of Traditional Chinese Medicine (2024) Vol. 10, Iss. 2, pp. 191-203
Open Access
Evaluation of the Efficacy, Safety, and Clinical Outcomes of Ginsenosides as Adjuvant Therapy in Hepatocellular Carcinoma: A Meta-Analysis and Systematic Review
Renjie Zhang, Yiling Liao, Yuan Gao, et al.
Integrative Cancer Therapies (2024) Vol. 23
Open Access
Renjie Zhang, Yiling Liao, Yuan Gao, et al.
Integrative Cancer Therapies (2024) Vol. 23
Open Access
Integrating UPLC‐MS/MS Bioinformatics and In Vivo Experiments Validation to Elucidate the Mechanism of Wenzi Jiedu Decoction in Suppressing Colorectal Cancer
Tianqing Sang, Alei Liang, Hongli Zhou, et al.
Phytochemical Analysis (2024)
Closed Access
Tianqing Sang, Alei Liang, Hongli Zhou, et al.
Phytochemical Analysis (2024)
Closed Access
Deciphering the underlying mechanism of liver diseases through utilization of multicellular hepatic spheroid models
Sanghwa Kim, Su‐Yeon Lee, Haeng Ran Seo
BMB Reports (2023) Vol. 56, Iss. 4, pp. 225-233
Open Access | Times Cited: 1
Sanghwa Kim, Su‐Yeon Lee, Haeng Ran Seo
BMB Reports (2023) Vol. 56, Iss. 4, pp. 225-233
Open Access | Times Cited: 1
